Back to Report Store Home

Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth

  • Published: Oct-2012
  • Report Code: GBIHC255MR
  • Report Format: pdf

Description

List of Tables

Table 1: Biopharmaceutical Manufacturing in India, China and South Korea, Biopharmaceutical Approvals, the US, 2012

Table 2: Biopharmaceutical Manufacturing in India, China and South Korea, Biopharmaceuticals Approved, the US, 2011

Table 3: Biopharmaceutical Manufacturing in India, China and South Korea, Biopharmaceuticals Approved, the US, 2010

Table 4: Biopharmaceutical Manufacturing in India, China and South Korea, Geographical Distribution of Cell Culture Capacity (000’ liters), 2011-2017

Table 5: Biopharmaceutical Manufacturing in India, China and South Korea, Volume Requirement for Different Biopharmaceuticals, (000’ liters), 2011-2017

Table 6: Biopharmaceutical Manufacturing, Product Demand Distribution in Monoclonal Antibodies (%), Global, 2011

Table 7: Biopharmaceutical Manufacturing, Global Sales of Leading Biologics and Year of Patent Expiry in the US and Europe

Table 8: Biopharmaceutical Manufacturing, Comparative Cost Analysis Between In-House Biopharmaceutical Production Versus CMOs, Global, 2011

Table 9: Biopharmaceutical Manufacturing in India, China and South Korea, Contract Manufacturing and the Drug Discovery and Research Market, Global, 2007-2016

Table 10: Biopharmaceutical Manufacturing, Labor Cost Analysis Comparison ($), the US, Europe, India, China, 2011

Table 11: Biopharmaceutical Manufacturing in India, China and South Korea, Investment Range for Manufacturing Plant Locations, Unit Cost per m3 ($), per m3 Reactor Volume, 2011

Table 12: Biopharmaceutical Manufacturing in India, China and South Korea, Average Cost for Product Development Activity, ($’000)

Table 13: Biopharmaceutical Manufacturing in India, China and South Korea, Major Products Manufactured in India, with Segmentation, 2011

Table 14: Biopharmaceutical Manufacturing in India, China and South Korea, Market for Vaccines in India ($m), 2011-2016

Table 15: Biopharmaceutical Manufacturing in India, China and South Korea, Biopharmaceutical Market in India ($bn), 2008-2016

Table 16: Biopharmaceutical Manufacturing in India, China and South Korea, Pharmaceutical and Biopharmaceutical Market ($bn), China, 2011-2015

Table 17: Biopharmaceutical Manufacturing in India, China and South Korea, Different Categories of Biopharmaceuticals, Expression System and Indications, China, 2011

Table 18: Biopharmaceutical Manufacturing in India, China and South Korea, Innovative Biopharmaceutical Products, Indications, KFDA Approval Year and Company, 1999-2011

Table 19: Biopharmaceutical Manufacturing in India, China and South Korea, Biopharmaceutical Market, South Korea ($bn), 2011-2016

Table 20: Biopharmaceutical Manufacturing in India, China and South Korea, Major R&D Achievements in South Korea

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards